RECRUITINGPhase 2 / Phase 3INTERVENTIONAL
Comparison of Standard vs. Accelerated Corneal Crosslinking
Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia
About This Trial
The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
Who May Be Eligible (Plain English)
Who May Qualify:
- Documented keratoconus or ectasia after refractive surgery
Who Should NOT Join This Trial:
- Insufficient corneal thickness
- Ocular condition that may predispose the eye to complications
- History of chemical injury or delayed epithelial healing
- Condition that would interfere with or prolong epithelial healing
- Known sensitivity to treatment medications
- Pregnancy
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Documented keratoconus or ectasia after refractive surgery
Exclusion Criteria:
* Insufficient corneal thickness
* Ocular condition that may predispose the eye to complications
* History of chemical injury or delayed epithelial healing
* Condition that would interfere with or prolong epithelial healing
* Known sensitivity to treatment medications
* Pregnancy
Treatments Being Tested
COMBINATION_PRODUCT
riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 9 mW/cm2 UVA light for 10 minutes
COMBINATION_PRODUCT
Riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 3 mW/cm2 UVA light for 30 minutes
Locations (1)
Price Vision Group
Indianapolis, Indiana, United States